PHARMA JAPAN welcomes JETRO New York’s Shunsuke Tani as a guest columnist. In occasional contributions, Tani will share his perspectives on US pharmaceutical policy, industry developments, and life in America, drawing on his firsthand experience in the US.---Hello from New…
HOME > Takeda’s £46 Billion Shire Buyout
Takeda’s £46 Billion Shire Buyout
-
Grilled by Shareholders, Takeda CEO Seeks Understanding for Shire Deal
June 29, 2018
-
Takeda Shareholders Strike Down Dissident Group’s Proposal
June 28, 2018
-
Angry Shareholders Say Don’t Make Takeda a Debt-Saddled Company
June 12, 2018
-
Takeda Inks US$7.5 billion Term Loan Credit to Refinance M&A Bridge
June 11, 2018
-
Takeda’s Founding Family-Backed Shareholders Demand Prior Vote for 1 Trillion Yen-Plus Deals
June 6, 2018
-
Perspective on Takeda/Shire Deal - 3: Takeda Shareholders Got Short End of the Stick
May 31, 2018
-
Perspective on Takeda/Shire Deal - 2: Acquisition Might Mint More Investment Opportunities, Positive or Negative Not Yet Clear
May 30, 2018
-
Perspective on Takeda/Shire Deal - 1: Profits Delivered by On-Market Products More Important than Pipeline
May 29, 2018
-
Takeda Confident It Can Reduce Debt Quickly after Shire Takeover: CEO
May 11, 2018
-
Shire Buyout a Must for Takeda’s Leap in Global Arena: Board Chair
May 10, 2018
-
Takeda Attracted to Shire’s High Profitability, Rare Disease Pipeline: CEO
May 9, 2018
-
Takeda Cuts Deal to Acquire Shire in Japan’s Biggest Buyout
May 8, 2018
-
Takeda, Shire Reach Preliminary Deal, Extend Takeover Deadline to May 8
April 25, 2018
-
Takeda Makes Fifth Pitch for Shire Buyout as Deadline Looms
April 25, 2018
-
Takeda Sweetens Bid for Shire, Ups Cash Component
April 23, 2018
-
Takeda in Talks with Shire after 3 Buyout Proposals Rejected
April 20, 2018
-
Takeda Mulls Takeover Bid for Shire
March 29, 2018
